ClinicalTrials.gov record
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
COMPLETED · NCT04681729
Trial record
NCT IDNCT04681729
Status
COMPLETED
Study type
INTERVENTIONAL
Phase
PHASE3
Enrollment
82
Conditions
Cold Urticaria
Interventions
Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine
Locations
Allergy and Asthma Medical Group and Research Center-Site Number:8400001, San Diego, California, United States, Treasure Valley Medical Research-Site Number:8400007, Boise, Idaho, United States, Allergy & Asthma Specialists, PSC-Site Number:8400003, Owensboro, Kentucky, United States, Johns Hopkins University (Asthma and Allergy Center)-Site Number:8400005, Baltimore, Maryland, United States, Bernstein Allergy Group Inc-Site Number:8400004, Cincinnati, Ohio, United States, Investigational Site Number :0320001, CABA, Buenos Aires, Argentina, Investigational Site Number :0320005, CABA, Buenos Aires, Argentina, Investigational Site Number :0320006, CABA, Buenos Aires, Argentina
Indexed topics
Last update
2025-09-09